A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

Clinical trial NCT05321082 · COMPLETED

Trial details

NCT number: NCT05321082
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Diseases, Interstitial

Start date: 2022-11-16
Primary completion: 2024-12-18
Enrollment: 1178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.